Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Advanced Colorectal Cancer
Clinical trial NCT06819280 · RECRUITING
Trial details
- NCT number
- NCT06819280
- Sponsor
- Grit Biotechnology
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-28
- Primary completion
- 2027-05-27
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.